UBS O'Connor’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-254,736	Closed	-$143K	–	607
2023 Q2	$143K	Sell	254,736 -21,692	-8%	-$12.1K	﹤0.01%	460
2023 Q1	$315K	Buy	+276,428	New	+$315K	0.01%	479
2022 Q4	–	Sell	-276,428	Closed	-$580K	–	560
2022 Q3	$580K	Buy	+276,428	New	+$580K	0.01%	780